Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Meningeal inflammation in multiple sclerosis: The key to the origin of cortical lesions?
Glatiramer Acetate 40 Mg/Ml Three Times A Week for The Treatment of Relapsing Forms of Multiple Sclerosis: Potential Cost Benefits of A Regimen With Infrequent Injections Which May Minimise Switching to The Newly-Introduced First-Line and Second-Line Dise
Endothelin-B Receptor Activation in Astrocytes Regulates the Rate of Oligodendrocyte Regeneration during Remyelination.
Nutrients, Microglia Aging, and Brain Aging.
The role of dopamine in modulation of Th-17 immune response in multiple sclerosis.
Optic neuritis as a phase 2 paradigm for neuroprotection therapies of multiple sclerosis: update on current trials and perspectives.
Neuropsychiatric Lupus: The Prevalence and Autoantibody Associations Depend on the Definition: Results from the 1000 Faces of Lupus Cohort.
Re: Hutchinson M, Fox RJ, Havrdova E, et al. Efficacy and safety of BG-12 (dimethyl fumarate) and other disease modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison. Curr Med
EDITORIAL Neuroglia as a Central Element of Neurological Diseases: An Underappreciated Target for Therapeutic Intervention.
Interdisciplinary exchange of ideas: progestagens for autoimmunity, biologics for pregnancy complications.
Intravenous administration of bone marrow-derived mesenchymal stem cells induces a switch from classical to atypical symptoms in experimental autoimmune encephalomyelitis.
Kaposi sarcoma in a patient with relapsing-remitting multiple sclerosis receiving fingolimod.
Myeloid-derived suppressor cells in immunity and autoimmunity.
MRI lesions as a surrogate for relapses in multiple sclerosis: a meta-analysis of randomised trials.
Subcutaneous vs intravenous administration of immunoglobulin in chronic inflammatory demyelinating polyneuropathy: an Italian cost-minimization analysis.
Optical neuritis induced by different concentrations of myelin oligodendrocyte glycoprotein presents different profiles of the inflammatory process.
Russell W Brain and the aetiology of multiple sclerosis--a historical perspective.
Soluble Tumor Necrosis Factor Receptor 1 Released by Skin-Derived Mesenchymal Stem Cells Is Critical for Inhibiting Th17 Cell Differentiation.
Role of Hemichannels in CNS Inflammation and the Inflammasome Pathway.
Therapeutic targeting of complement to modify disease course and improve outcomes in neurological conditions.
Baseline Differences in Minor Lymphocyte Subpopulations may Predict Response to Fingolimod in Relapsing-Remitting Multiple Sclerosis Patients.
Endocannabinoids and the Immune System in Health and Disease.
Generation and preclinical characterization of an antibody specific for SEMA4D.
Noise robust spatially regularized myelin water fraction mapping with the intrinsic B1 -error correction based on the linearized version of the extended phase graph model.
Atypical presentation of multiple sclerosis.

Pages